Business Context and Reporting Period
This summary covers the Form 10-Q filed by On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.) for the quarterly period ended September 30, 2001. The company operates in two segments: Lab Support and Healthcare Staffing, providing temporary and permanent placement services for laboratory, scientific, and medical professionals.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2001 | Nine Months Ended Sep 30, 2001 |
|---|---|---|
| Revenues | $46,943,000 | $147,798,000 |
| Net Income | $4,059,000 | $13,388,000 |
| Diluted EPS | $0.18 | $0.58 |
| Operating Income | $5,769,000 | $19,029,000 |
| Cash from Operations (9mo) | $20,668,000 | |
| Cash & Equivalents (Sep 30, 2001) | $62,427,000 | |
| Total Assets | $117,607,000 | |
| Total Liabilities | $10,475,000 (Current) |
Margins (Nine Months 2001): Gross Margin was 32.4%; Operating Margin was 12.9%.
Material Changes vs. Prior Period
- Quarterly Revenue Decline: Revenues decreased 8.2% to $46.9 million compared to the prior year quarter. This was driven by an 8.0% decline in the Lab Support segment and an 8.6% decline in Healthcare Staffing.
- Volume vs. Rates: The revenue decline was primarily due to decreases in the average number of temporary employees on assignment (down 11.0% in Lab Support, 12.7% in Healthcare) and significant drops in conversion fee revenue. These volume declines were partially offset by increases in average billing rates (4.6% in Lab Support, 5.9% in Healthcare).
- Year-to-Date Growth: For the nine months ended September 30, revenues increased 3.2% to $147.8 million, driven by higher billing rates despite a slight decrease in employee volume.
- Expense Trends: Cost of services as a percentage of revenue increased slightly in both segments due to higher workers' compensation insurance premiums and increased employer-paid benefits. Selling, general, and administrative (SG&A) expenses increased 0.3% quarterly and 8.8% year-to-date, largely due to hiring new Account Managers for office expansions.
- Stock Repurchases: The company repurchased 473,500 shares of common stock during the nine-month period for $7.5 million, bringing total repurchases under authorization to 1.13 million shares.
Guidance, Outlook, and Risks
- Management Commentary: Management attributes the quarterly revenue decline to lower temporary employee volume and reduced conversion fees. They note that higher billing rates helped mitigate the impact. The increase in SG&A is attributed to strategic expansion and new office openings.
- Liquidity: The company maintains strong liquidity with $62.4 million in cash and cash equivalents. Management expects internally generated cash and borrowing ability to be sufficient for working capital needs.
- Accounting Changes: The company is evaluating the impact of new FASB standards (SFAS No. 141 and 142) regarding business combinations and goodwill, which will be adopted in fiscal 2002. These standards require testing goodwill for impairment rather than amortization.
- Risks: Key risks include the ability to attract and retain qualified staff, management of growth in international markets, and integration of acquired operations. The company notes that interest rate risk is immaterial due to short maturities of investments.
- Executive Changes: Dr. Joe Peterson was selected as Chief Executive Officer and President effective September 1, 2001, succeeding Kathy West who retired.
Investor Verification Checklist
- Verify the sustainability of the 4.6% to 5.9% increase in average billing rates against the 11% to 12.7% decline in temporary employee volume.
- Monitor the impact of rising workers' compensation premiums on gross margins in future quarters.
- Assess the effectiveness of new office expansions and Account Manager hiring in reversing the quarterly revenue decline.
- Review the potential financial impact of the upcoming adoption of SFAS No. 142 on goodwill impairment testing.
- Confirm the status of the remaining stock repurchase authorization (1.8 million shares remaining).